Strattera (Atomoxetine) Dosing
Start atomoxetine at 40 mg once daily in adults and patients over 70 kg, or 0.5 mg/kg/day in children and adolescents up to 70 kg, then increase after a minimum of 3 days to a target dose of 80 mg daily (or 1.2 mg/kg/day), with a maximum of 100 mg daily. 1
Initial Dosing
Children and Adolescents ≤70 kg
- Starting dose: 0.5 mg/kg/day 1
- Target dose: 1.2 mg/kg/day after minimum 3 days 1
- Maximum dose: 1.4 mg/kg/day or 100 mg daily, whichever is less 1
- Can be given as single morning dose or divided into morning and late afternoon/evening doses 1
Children and Adolescents >70 kg and Adults
- Starting dose: 40 mg once daily 1
- Target dose: 80 mg daily after minimum 3 days 1
- Maximum dose: 100 mg daily after 2-4 additional weeks if optimal response not achieved 1
- No data support increased effectiveness at doses higher than the target 1
Titration Guidelines
Increase doses slowly at 1-2 week intervals using the smallest available increments to minimize behavioral activation and optimize tolerability. 2
- Maintain initial dose for at least 1-2 weeks before increasing 2
- Increase by small increments (typically 10-25 mg) no more frequently than every 1-2 weeks 2
- Rapid dose escalation can cause behavioral activation, agitation, motor restlessness, insomnia, impulsiveness, and aggression, particularly in younger patients 2
- If side effects occur, return to the previous well-tolerated dose 2
Special Populations
Hepatic Impairment
- Moderate hepatic insufficiency (Child-Pugh Class B): Reduce initial and target doses to 50% of normal 1
- Severe hepatic insufficiency (Child-Pugh Class C): Reduce initial and target doses to 25% of normal 1
CYP2D6 Poor Metabolizers or Concurrent Strong CYP2D6 Inhibitors
When using strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) or in known CYP2D6 poor metabolizers:
- Children/adolescents ≤70 kg: Start at 0.5 mg/kg/day, increase to 1.2 mg/kg/day only if symptoms fail to improve after 4 weeks and initial dose is well tolerated 1
- Children/adolescents >70 kg and adults: Start at 40 mg/day, increase to 80 mg/day only if symptoms fail to improve after 4 weeks and initial dose is well tolerated 1
Administration Details
- Can be taken with or without food 1
- Capsules must be swallowed whole, not opened 1
- Can be discontinued without tapering 1
- Single doses over 120 mg and total daily doses above 150 mg have not been systematically evaluated 1
Timeline for Response
Set appropriate expectations: atomoxetine requires 6-12 weeks to achieve full therapeutic effect, unlike stimulants which work within hours. 2
- This delayed response timeline is critical for patient adherence 2
- Symptoms typically return upon discontinuation 2
Safety Monitoring
- Screen for personal or family history of bipolar disorder, mania, or hypomania before initiating 1
- Monitor closely for suicidality, clinical worsening, and unusual behavioral changes, especially during the first few months or with dose changes 2
- Monitor blood pressure and heart rate at baseline, 1 week, and with each dose adjustment 3
- Common adverse effects include nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence 2